Ignite Creation Date:
2024-05-06 @ 2:10 AM
Last Modification Date:
2024-10-26 @ 11:14 AM
Study NCT ID:
NCT01983904
Status:
COMPLETED
Last Update Posted:
2019-04-18
First Post:
2013-11-07
Brief Title:
DBS for Treatment Resistant Depression
Sponsor:
University of Calgary
Organization:
University of Calgary
Study Overview
Official Title:
Therapeutic Brain Stimulation for Refractory Depression
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CRIO-DBS
Brief Summary:
The purpose of this study is to examine the effects of sub-callosal cingulate SCC deep brain stimulation DBS in patients with treatment resistant depression TRD
The working hypotheses are that long pulse-width DBS applied to the SCC region will lead to improvements in TRD patients and specific neuroimaging biomarkers will correlate with response to DBS the functional recovery will be enhanced with concurrent cognitive behavioural therapy CBT
The working hypotheses are that long pulse-width DBS applied to the SCC region will lead to improvements in TRD patients and specific neuroimaging biomarkers will correlate with response to DBS the functional recovery will be enhanced with concurrent cognitive behavioural therapy CBT
Detailed Description:
The aim is to collect data on prediction optimization and augmentation of DBS for TRD and develop tools for DBS surgery It is a biological pilot study designed to provide informative data for future work
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None